Metropolitan Life Insurance Company (MetLife)’s CBRE Group CBRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-11,994
Closed -$1.17M – 373
2024
Q1
$1.17M Sell
11,994
-412
-3% -$37K 0.05% 304
2023
Q4
$1.15M Sell
12,406
-412
-3% -$32K 0.05% 292
2023
Q3
$947K Sell
12,818
-727
-5% -$60.3K 0.05% 304
2023
Q2
$1.09M Sell
13,545
-586
-4% -$43.9K 0.05% 307
2023
Q1
$1.03M Sell
14,131
-4,142
-23% -$338K 0.05% 315
2022
Q4
$1.41M Sell
18,273
-507
-3% -$37.4K 0.06% 291
2022
Q3
$1.27M Sell
18,780
-562
-3% -$44.5K 0.06% 295
2022
Q2
$1.42M Sell
19,342
-960
-5% -$77.3K 0.06% 290
2022
Q1
$1.86M Sell
20,302
-18,409
-48% -$1.79M 0.07% 278
2021
Q4
$4.2M Sell
38,711
-1,573
-4% -$161K 0.06% 271
2021
Q3
$3.92M Sell
40,284
-43,109
-52% -$4.01M 0.06% 267
2021
Q2
$7.15M Buy
83,393
+41,982
+101% +$3.58M 0.05% 289
2021
Q1
$3.28M Sell
41,411
-2,029
-5% -$143K 0.05% 326
2020
Q4
$2.72M Sell
43,440
-1,264
-3% -$71.4K 0.04% 364
2020
Q3
$2.1M Sell
44,704
-2,009
-4% -$91.7K 0.04% 401
2020
Q2
$2.11M Sell
46,713
-8,636
-16% -$372K 0.04% 385
2020
Q1
$2.09M Sell
55,349
-466
-0.8% -$25.8K 0.04% 367
2019
Q4
$3.42M Sell
55,815
-1,215
-2% -$67.3K 0.05% 306
2019
Q3
$3.02M Buy
57,030
+2,119
+4% +$111K 0.05% 316
2019
Q2
$2.82M Buy
54,911
+2,763
+5% +$137K 0.05% 352
2019
Q1
$2.58M Sell
52,148
-1,935
-4% -$90.8K 0.05% 352
2018
Q4
$2.17M Buy
54,083
+786
+1% +$32.5K 0.04% 380
2018
Q3
$2.35M Buy
53,297
+67
+0.1% +$3.19K 0.04% 429
2018
Q2
$2.54M Buy
53,230
+1,344
+3% +$63.6K 0.04% 395
2018
Q1
$2.45M Buy
51,886
+280
+0.5% +$12.8K 0.03% 418
2017
Q4
$2.23M Sell
51,606
-96,438
-65% -$4M 0.03% 478
2017
Q3
$5.61M Sell
148,044
-2,563
-2% -$94.3K 0.04% 517
2017
Q2
$5.48M Sell
150,607
-10,351
-6% -$360K 0.04% 519
2017
Q1
$5.6M Sell
160,958
-2,039
-1% -$68.2K 0.04% 516
2016
Q4
$5.13M Sell
162,997
-2,861
-2% -$82.8K 0.04% 554
2016
Q3
$4.64M Buy
165,858
+1,277
+0.8% +$36.4K 0.03% 578
2016
Q2
$4.36M Buy
164,581
+14
+0% +$409 0.03% 595
2016
Q1
$4.74M Sell
164,567
-2,189
-1% -$60.2K 0.04% 541
2015
Q4
$5.77M Sell
166,756
-1,619
-1% -$57.1K 0.04% 429
2015
Q3
$5.39M Buy
168,375
+2,382
+1% +$84.5K 0.04% 467
2015
Q2
$6.14M Buy
165,993
+1,584
+1% +$60.1K 0.04% 440
2015
Q1
$6.36M Sell
164,409
-1,987
-1% -$68.5K 0.05% 413
2014
Q4
$5.7M Sell
166,396
-1,564
-0.9% -$50K 0.04% 473
2014
Q3
$5M Sell
167,960
-2,645
-2% -$83.1K 0.04% 511
2014
Q2
$5.47M Sell
170,605
-7,791
-4% -$225K 0.04% 496
2014
Q1
$4.89M Sell
178,396
-2,413
-1% -$65.1K 0.03% 552
2013
Q4
$4.75M Sell
180,809
-3,170
-2% -$75.4K 0.03% 541
2013
Q3
$4.25M Sell
183,979
-17,259
-9% -$400K 0.03% 555
2013
Q2
$4.7M Buy
+201,238
New +$4.79M 0.04% 472

Other funds holding CBRE

Metropolitan Life Insurance Company (MetLife)'s CBRE Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of CBRE Group (CBRE) in Q2 2024, closing a stake of 11,994 shares — an estimated $1.17M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CBRE in Q2 2013 and held it in 44 quarters. The position peaked at $7.15M in Q2 2021. 782 funds tracked by Wall St. Rank hold CBRE as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining CBRE Group position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 11,994 CBRE Group shares in Q2 2024, an estimated $1.17M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in CBRE Group in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s CBRE Group position peaked at $7.15M in Q2 2021.
  • 782 funds tracked by Wall St. Rank held CBRE Group as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.